Osaic Holdings
SRPT icon

Osaic Holdings’s Sarepta Therapeutics SRPT Stock Holding History

Osaic Holdings’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Buy
11,801
+2,542
+27% +$48.1K ﹤0.01% 4388
2026
Q1 		$201K Buy
9,259
+3,830
+71% +$74.1K ﹤0.01% 4129
2025
Q4 		$117K Sell
5,429
-1,800
-25% -$37.9K ﹤0.01% 4582
2025
Q3 		$135K Buy
7,229
+3,101
+75% +$55.3K ﹤0.01% 4539
2025
Q2 		$95.1K Buy
4,128
+967
+31% +$41.3K ﹤0.01% 4542
2025
Q1 		$202K Sell
3,161
-1,506
-32% -$159K ﹤0.01% 3618
2024
Q4 		$567K Sell
4,667
-3,058
-40% -$375K ﹤0.01% 2676
2024
Q3 		$965K Buy
7,725
+4,679
+154% +$647K ﹤0.01% 2275
2024
Q2 		$481K Sell
3,046
-2,990
-50% -$384K ﹤0.01% 2804
2024
Q1 		$781K Sell
6,036
-547
-8% -$67K ﹤0.01% 2555
2023
Q4 		$635K Sell
6,583
-7,385
-53% -$708K ﹤0.01% 2952
2023
Q3 		$1.69M Sell
13,968
-6,620
-32% -$748K ﹤0.01% 2153
2023
Q2 		$2.36M Sell
20,588
-4,073
-17% -$525K ﹤0.01% 1722
2023
Q1 		$3.4M Buy
24,661
+16,332
+196% +$2.12M 0.01% 1423
2022
Q4 		$1.08M Buy
8,329
+4,120
+98% +$477K ﹤0.01% 2296
2022
Q3 		$464K Sell
4,209
-193
-4% -$19.5K ﹤0.01% 2968
2022
Q2 		$329K Sell
4,402
-436
-9% -$32.1K ﹤0.01% 3344
2022
Q1 		$378K Sell
4,838
-425
-8% -$32.5K ﹤0.01% 3489
2021
Q4 		$475K Sell
5,263
-1,536
-23% -$131K ﹤0.01% 3114
2021
Q3 		$628K Sell
6,799
-488
-7% -$37.6K ﹤0.01% 2803
2021
Q2 		$566K Buy
7,287
+578
+9% +$43.8K ﹤0.01% 2893
2021
Q1 		$500K Buy
6,709
+1,405
+26% +$130K ﹤0.01% 2862
2020
Q4 		$904K Sell
5,304
-1,014
-16% -$150K ﹤0.01% 2126
2020
Q3 		$887K Buy
6,318
+594
+10% +$90.3K ﹤0.01% 1947
2020
Q2 		$917K Sell
5,724
-7,700
-57% -$1.05M ﹤0.01% 1816
2020
Q1 		$596K Buy
+13,424
New +$1.53M ﹤0.01% 1926

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Osaic Holdings's SRPT Position: Q2 2026 in Review

Osaic Holdings increased its Sarepta Therapeutics (SRPT) stake by 27% in Q2 2026, buying an estimated $48.1K and bringing the position to 11,801 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #4388.

Osaic Holdings first reported a position in SRPT in Q1 2020 and has held it in 26 quarters since. The position peaked at $3.4M in Q1 2023. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Osaic Holdings held 11,801 shares of Sarepta Therapeutics worth $212K as of Q2 2026.
  • Osaic Holdings bought 2,542 Sarepta Therapeutics shares in Q2 2026, an estimated $48.1K.
  • Sarepta Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4388 holding.
  • Osaic Holdings first reported a position in Sarepta Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Sarepta Therapeutics position peaked at $3.4M in Q1 2023.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.